Clinical Trials Browser

Urologic Neoplasms × Methyltestosterone × 90 days × Clear all

NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Phase 1 Active not recruiting

Hypogonadism, Urologic Diseases, Urologic Neoplasms